Peter J. Little

15.6k citations

331 papers · 12.4k indexed · 5 hit papers · h-index 61

Impact in

Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases

Papers in

Immunology and Allergy 20
- Cell Adhesion Molecules Research 20
Molecular Biology 163
- Protein Kinase Regulation and GTPase Signaling 29
- TGF-β signaling in diseases 25
- Receptor Mechanisms and Signaling 21
- Metabolism, Diabetes, and Cancer 21
- Peroxisome Proliferator-Activated Receptors 21

Co-authors: Suowen Xu Narin Osman Danielle Kamato Alex Bobik Wenhua Zheng Jianping Weng Micah L. Burch Mandy L. Ballinger
Journals: Clinical and Experimental Pharmacology and Physiology (11 papers)Journal of Pharmacy and Pharmacology (9 papers)Cellular and Molecular Life Sciences (8 papers)Journal of Biological Chemistry (7 papers)Journal of Cardiovascular Pharmacology (6 papers)
Partner nations: Australia China United States

In The Last Decade

Peter J. Little

327 papers receiving 12.2k citations

Hit Papers

5 papers align trajectories log scale

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies 2023 · 142 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Signal Transduction and Targeted Therapy
2022 Frontiers in Cardiovascular Medicine
2021 Pharmacological Reviews
2021 International Journal of Biological Sciences
2017 International Journal of Biological Sciences

Peers

Countries citing papers authored by Peter J. Little

Since Specialization

Citations

This map shows the geographic impact of Peter J. Little's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Little with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Little more than expected).

Fields of papers citing papers by Peter J. Little

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Little. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Little. The network helps show where Peter J. Little may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter J. Little, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. Little Line = papers co-authored together Peter J. Little links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice Acta Pharmaceutica Sinica B ·Meijie Chen, Peter J. Little, Sudong Kong, Maciej Banach, Jianping Weng, (unknown)	2024	1
2	Transforming growth factor-β receptors: versatile mechanisms of ligand activation Acta Pharmacologica Sinica ·Zheng-Jie Chia, Yingnan Cao, Peter J. Little, Danielle Kamato	2024	40
3	Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling Acta Pharmacologica Sinica ·Zheng-Jie Chia, Hirushi Kumarapperuma, Ruizhi Zhang, Peter J. Little, Danielle Kamato	2024	4
4	Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway Acta Pharmacologica Sinica ·Xiayun Ni, Xiaojun Feng, Zhihua Wang, Yang Zhang, Peter J. Little, Yang Cao, Suowen Xu, Liqin Tang, Jianping Weng	2024	12
5	The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review Journal of Pharmacy and Pharmacology ·Wei Yu, Yaping Zhao, Iqra Ilyas, Li Wang, Peter J. Little, Suowen Xu	2024	2
6	Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery Acta Pharmacologica Sinica ·Si Gao, Xueping Liu, Tingting Li, Li Chen, Yiping Feng, Yukun Wang, Yanjun Yin, Peter J. Little, Xiaoqian Wu, Suowen Xu, Xudong Jiang	2023	21
7	Kaempferol and atherosclerosis: From mechanism to medicine Critical Reviews in Food Science and Nutrition ·Meijie Chen, Jianbo Xiao, Hesham R. El‐Seedi, Krystyna Skalicka‐Woźniak, Maria Daglia, Peter J. Little, Jianping Weng, Suowen Xu	2022	62
8	GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential International Journal of Biological Sciences ·Xiaoxuan Ma, Zhenghong Liu, Iqra Ilyas, Peter J. Little, Danielle Kamato, Amirhossein Sahebka, Zhengfang Chen, Sihui Luo, Xueying Zheng, Jianping Weng, Suowen Xu Hit paper breakdown →	2021	188
9	Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis Nanoscale ·Hang T. Ta, Nina Arndt, Yuao Wu, Hui Jean Lim, Shea Landeen, Run Zhang, Danielle Kamato, Peter J. Little, Andrew K. Whittaker, Zhi Ping Xu	2018	54
10	Novel iron oxide–cerium oxide core–shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases Journal of Materials Chemistry B ·Yuao Wu, Yanchen Yang, Wei Zhao, Zhi Ping Xu, Peter J. Little, Andrew K. Whittaker, Run Zhang, Hang T. Ta	2018	84
11	Changing environment of hyperglycemia in pregnancy: Gestational diabetes and diabetes mellitus in pregnancy Journal of Diabetes ·Susan Gray, Arianne Sweeting, Treasure McGuire, Neale Cohen, Glynis P. Ross, Peter J. Little	2018	12
12	Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP Archives of Physiology and Biochemistry ·Peter J. Little, Katherine Drennon, Lisa R. Tannock	2008	15
13	Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents Journal of Diabetes and its Complications ·Stephanie T. de Dios, Karen V. Frontanilla, Julie Nigro, Mandy L. Ballinger, Melanie E. Ivey, Elizabeth A. Cawson, Peter J. Little	2007	25
14	Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-γ Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation Circulation ·Stephanie T. de Dios, Dennis Bruemmer, Rodney J. Dilley, Melanie E. Ivey, Garry Jennings, Ronald E. Law, Peter J. Little	2003	79
15	Overnight urinary norepinephrine and awake pulmonary capillary wedge pressure in heart failure with central sleep apnea. Respirology ·Peter Solin, Peter J. Little, Teanau Roebuck, Michael R. Richardson, Peter Bergin, David M. Kaye, E. Haydn Walters, MT Naughton	1999	1
16	Rapid regulation of adrenomedullin in metabolically compromised vascular smooth muscle cells Journal of Hypertension ·Dominic J. Autelitano, Fai Tang, Peter J. Little	1999	11
17	ASR volume 39 issue 1 Cover and Front matter African Studies Review ·Mark W. DeLancey, Susan Dicklich, Karen Rader, Catherine Russell, Michael Kuchinsky, Kenneth W. Grundy, Melvin W. Hanna, Peter J. Little, Edward O. Erhagbe, Lila Ammons, Gregory H. Maddox, Kevin P. Hill, Matthew Costello, Kevin Dunn	1996	1
18	Urinary stones: a prospective study of 350 patients. PubMed ·Bailey Rr, Eldad J. Dann, Greenslade Nf, Peter J. Little, McRae Cu, Utley Wl	1974	9
19	Tetracyclines and renal failure. PubMed ·Peter J. Little, Bailey Rr	1970	27
20	THE INCIDENCE OF URINARY INFECTION IN 5000 PREGNANT WOMEN The Lancet ·Peter J. Little	1966	119

About Peter J. Little

Peter J. Little is a scholar working on Immunology and Allergy, Molecular Biology, Endocrinology, Diabetes and Metabolism, Biochemistry and Cell Biology, having authored 331 papers that have together received 12.4k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (29 papers), Proteoglycans and glycosaminoglycans research (27 papers), TGF-β signaling in diseases (25 papers), Nitric Oxide and Endothelin Effects (24 papers), Receptor Mechanisms and Signaling (21 papers), Metabolism, Diabetes, and Cancer (21 papers), Peroxisome Proliferator-Activated Receptors (21 papers) and Cell Adhesion Molecules Research (20 papers). The work is most often cited by research in Immunology and Allergy (557 citations), Immunology (1.8k citations), Cancer Research (1.2k citations), Molecular Biology (5.5k citations) and Complementary and alternative medicine (640 citations). Peter J. Little has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Suowen Xu, Narin Osman, Danielle Kamato, Alex Bobik, Wenhua Zheng, Jianping Weng, Micah L. Burch, Mandy L. Ballinger, Peiqing Liu and Julie Nigro. Their work appears in journals such as Clinical and Experimental Pharmacology and Physiology, Journal of Pharmacy and Pharmacology, Cellular and Molecular Life Sciences, Journal of Biological Chemistry and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact